The WHO Global NCD Action Plan 2013-2020 provides a road map to attain nine voluntary global targets, including that of a 25% relative reduction in premature mortality from cardiovascular diseases, cancer, diabetes or chronic respiratory diseases by 2025. Over the last 4.5 years, staff at the CEBM have been working towards the actualisation of the WHO Global NCD Action Plan.
The last WHO working meeting on the development of screening guidelines for cardiovascular disease (CVD) risk took place on November 6-7, 2013 at Geneva. Carl Heneghan chaired the meeting, which included participants from across the globe. Igho Onakpoya presented the synthesized evidence on the benefits and harms of CVD risk screening. Using the GRADE methodology, the evidence presented was used to develop a set of recommendations on screening for CVD risk including diabetes.
A provisional draft based on the recommendations developed at the meeting has been written by Igho Onakpoya, Alison Ward and Carl Heneghan, and is presently under consideration. The CVD risk screening guideline should be available in 2014.
Image – A snapshot of participants at the WHO meeting on guidelines development for CVD risk screening (including diabetes) held at Geneva, Switzerland, November 6-7, 2013.